Lactic Acid Bacteria System
Reported by Marcia Brady | February 6th, 2024 @ 08:04 AM
Lactic acid bacteria (LAB) are considered potential candidates as mucosal vaccine vectors. One major advantage of recombinant LAB strains as delivery vehicles for vaccines is their potential to elicit specific systemic and mucosal immune responses against selected antigens. One vaccine is Whole-Cell LAB-Based Vaccines that express the receptor binding domain (RBD) of the SARS-CoV-2. The spike (S) protein of coronaviruses mediates receptor binding and membrane fusion and is crucial for determining host tropism and transmission capacity.
No comments found
Please Sign in or create a free account to add a new ticket.
With your very own profile, you can contribute to projects, track your activity, watch tickets, receive and update tickets through your email and much more.
Create new ticket
Create your profile
Help contribute to this project by taking a few moments to create your personal profile. Create your profile »
Marcia Brady